The LymeX Diagnostics Prize has revealed its Phase 3 winners, each awarded $420,000, in a competition aimed at accelerating the development of innovative diagnostics for Lyme disease. These teams, including BlueArc Biosciences Inc. and Drexel University College of Medicine, have developed promising tests for early detection and treatment tracking of Lyme disease. The competition, supported by a $10 million pledge, now moves into Phase 4, focusing on clinical validation studies and FDA submissions.